_id
691b16703c536f8df2318bb8
Ticker
MEDCL.PA
Name
Medincell SA
Exchange
PA
Address
3 Rue des Frères Lumière, Jacou, France, 34830
Country
France
Sector
Healthcare
Industry
Biotechnology
Currency
EUR
Website
https://www.medincell.com
Description
MedinCell S.A., a clinical-stage and commercial biopharmaceutical licensing company, develops long acting injectables in various therapeutic areas in France. The company develops solutions based on BEPO, a long-acting injectable technology. It offers UZEDY (mdc-IRM) for the treatment of schizophrenia in adults and bipolar I disorder. It is also developing mdc-TJK, a subcutaneous injection that is in the NDA preparation stage for the treatment of schizophrenia in adults; and mdc-CWM, a sustained-release formulation of celecoxib in Phase III trials for use in the treatment of reduction of postoperative pain and inflammation in total knee arthroplasty surgery. In addition, its product candidates in preclinical trials include mdc-WWM for contraception; and mdc-STM for malaria. It has strategic collaborations with AbbVie to develop, manufacture, and commercialize six long-acting injectable therapeutic products; and IM4TB to develop a long-acting injectable version of Macozinone for the treatment of tuberculosis. MedinCell S.A. was incorporated in 2003 and is based in Jacou, France.
Last Close
24.62
Volume
52952
Current Price
25.48
Change
0.54
Last Updated
2025-12-31T15:57:24.416Z
Image
https://logo.clearbit.com/www.medincell.com
Ipo Date
-
Market Cap
1272154496
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.383
Sentiment Sources
2
Rating
4
Strong Buy
1
Buy
6
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
11608000
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
19811000
Operating Income
-9149000
Interest Expense
2842000
Pretax Income
-18585000
Net Income
-16078000
Eps
-0.4859769004702804
Dividends Per Share
-
Shares Outstanding
33125992
Income Tax Expense
-2507000
EBITDA
-14797000
Operating Margin
-78.81633356305996
Total Other Income Expense Net
-9436000
Cash
19472000
Short Term Investments
34030000
Receivables
6865000
Inventories
-
Total Current Assets
61356000
Property Plant Equipment
4842000
Total Assets
74577000
Payables
3661000
Short Term Debt
5623000
Long Term Debt
-
Total Liabilities
105209000
Equity
-30632000
Bs_currency_symbol
-
Depreciation
946000
Change In Working Capital
-9572000
Cash From Operations
-14253000
Capital Expenditures
230000
Cash From Investing
7559000
Cash From Financing
-2580000
Net Change In Cash
1375000
Cf_currency_symbol
-
PE
-
PB
-27.519495493601465
ROE
52.48759467223818
ROA
-21.558925674135455
FCF
-14483000
Fcf Percent
-1.2476740179186767
Piotroski FScore
1
Health Score
31
Deep Value Investing Score
0.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
2.5
Growth Investing Score
2.5
Momentum Investing Score
2.5
Net Net Investing Score
0.5
Quality Investing Score
2.5
Value Investing Score
2.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
11608000
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
19811000
Quarters > 0 > income Statement > operating Income
-9149000
Quarters > 0 > income Statement > interest Expense
2842000
Quarters > 0 > income Statement > pretax Income
-18585000
Quarters > 0 > income Statement > net Income
-16078000
Quarters > 0 > income Statement > eps
-0.4859769004702804
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
33083877
Quarters > 0 > income Statement > income Tax Expense
-2507000
Quarters > 0 > income Statement > EBITDA
-14797000
Quarters > 0 > income Statement > operating Margin
-78.81633356305996
Quarters > 0 > income Statement > total Other Income Expense Net
-9436000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
19472000
Quarters > 0 > balance Sheet > short Term Investments
34030000
Quarters > 0 > balance Sheet > receivables
6865000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
61356000
Quarters > 0 > balance Sheet > property Plant Equipment
4842000
Quarters > 0 > balance Sheet > total Assets
74577000
Quarters > 0 > balance Sheet > payables
3661000
Quarters > 0 > balance Sheet > short Term Debt
5623000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
105209000
Quarters > 0 > balance Sheet > equity
-30632000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-16078000
Quarters > 0 > cash Flow > depreciation
946000
Quarters > 0 > cash Flow > change In Working Capital
-9572000
Quarters > 0 > cash Flow > cash From Operations
-14253000
Quarters > 0 > cash Flow > capital Expenditures
230000
Quarters > 0 > cash Flow > cash From Investing
7559000
Quarters > 0 > cash Flow > cash From Financing
-2580000
Quarters > 0 > cash Flow > net Change In Cash
1375000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.4859769004702804
Quarters > 0 > ratios > PB
-27.519495493601465
Quarters > 0 > ratios > ROE
52.48759467223818
Quarters > 0 > ratios > ROA
-21.558925674135455
Quarters > 0 > ratios > FCF
-14483000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-1.2476740179186767
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
16106000
Quarters > 1 > income Statement > cost Of Revenue
720000
Quarters > 1 > income Statement > gross Profit
16106000
Quarters > 1 > income Statement > operating Expenses
21603000
Quarters > 1 > income Statement > operating Income
-3311000
Quarters > 1 > income Statement > interest Expense
2567000
Quarters > 1 > income Statement > pretax Income
-3839000
Quarters > 1 > income Statement > net Income
-3870000
Quarters > 1 > income Statement > eps
-0.12156505299372476
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
31834807
Quarters > 1 > income Statement > income Tax Expense
31000
Quarters > 1 > income Statement > EBITDA
-3941000
Quarters > 1 > income Statement > operating Margin
-20.557556190239662
Quarters > 1 > income Statement > total Other Income Expense Net
-528000
Quarters > 1 > income Statement > currency_symbol
EUR
Quarters > 1 > balance Sheet > cash
59040000
Quarters > 1 > balance Sheet > short Term Investments
12857000
Quarters > 1 > balance Sheet > receivables
3205000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
80617000
Quarters > 1 > balance Sheet > property Plant Equipment
5274000
Quarters > 1 > balance Sheet > total Assets
90452000
Quarters > 1 > balance Sheet > payables
3997000
Quarters > 1 > balance Sheet > short Term Debt
7294000
Quarters > 1 > balance Sheet > long Term Debt
49417000
Quarters > 1 > balance Sheet > total Liabilities
106819000
Quarters > 1 > balance Sheet > equity
-16367000
Quarters > 1 > balance Sheet > currency_symbol
EUR
Quarters > 1 > cash Flow > net Income
-3870000
Quarters > 1 > cash Flow > depreciation
1150000
Quarters > 1 > cash Flow > change In Working Capital
-2710000
Quarters > 1 > cash Flow > cash From Operations
-2845000
Quarters > 1 > cash Flow > capital Expenditures
552000
Quarters > 1 > cash Flow > cash From Investing
-6874000
Quarters > 1 > cash Flow > cash From Financing
37130000
Quarters > 1 > cash Flow > net Change In Cash
2655000
Quarters > 1 > cash Flow > currency_symbol
EUR
Quarters > 1 > ratios > PE
-0.12156505299372476
Quarters > 1 > ratios > PB
-49.56014433677522
Quarters > 1 > ratios > ROE
23.645139610191237
Quarters > 1 > ratios > ROA
-4.278512360146818
Quarters > 1 > ratios > FCF
-3397000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.21091518688687447
Quarters > 1 > health Score
31
Quarters > 2 > quarter
2024-09-30
Quarters > 2 > income Statement > revenue
9435000
Quarters > 2 > income Statement > cost Of Revenue
434000
Quarters > 2 > income Statement > gross Profit
9435000
Quarters > 2 > income Statement > operating Expenses
16964000
Quarters > 2 > income Statement > operating Income
-7529000
Quarters > 2 > income Statement > interest Expense
1774000
Quarters > 2 > income Statement > pretax Income
-14439000
Quarters > 2 > income Statement > net Income
-14568000
Quarters > 2 > income Statement > eps
-0.5006009238506204
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
29101025
Quarters > 2 > income Statement > income Tax Expense
129000
Quarters > 2 > income Statement > EBITDA
-7259000
Quarters > 2 > income Statement > operating Margin
-79.79862215156332
Quarters > 2 > income Statement > total Other Income Expense Net
-6910000
Quarters > 2 > income Statement > currency_symbol
EUR
Quarters > 2 > balance Sheet > cash
31636000
Quarters > 2 > balance Sheet > short Term Investments
7217000
Quarters > 2 > balance Sheet > receivables
2877000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
47752000
Quarters > 2 > balance Sheet > property Plant Equipment
5176000
Quarters > 2 > balance Sheet > total Assets
58863000
Quarters > 2 > balance Sheet > payables
2365000
Quarters > 2 > balance Sheet > short Term Debt
7544000
Quarters > 2 > balance Sheet > long Term Debt
49878000
Quarters > 2 > balance Sheet > total Liabilities
112893000
Quarters > 2 > balance Sheet > equity
-54030000
Quarters > 2 > balance Sheet > currency_symbol
EUR
Quarters > 2 > cash Flow > net Income
-14568000
Quarters > 2 > cash Flow > depreciation
840000
Quarters > 2 > cash Flow > change In Working Capital
26729000
Quarters > 2 > cash Flow > cash From Operations
21559000
Quarters > 2 > cash Flow > capital Expenditures
195000
Quarters > 2 > cash Flow > cash From Investing
-6993000
Quarters > 2 > cash Flow > cash From Financing
-2398000
Quarters > 2 > cash Flow > net Change In Cash
31636000
Quarters > 2 > cash Flow > currency_symbol
EUR
Quarters > 2 > ratios > PE
-0.5006009238506204
Quarters > 2 > ratios > PB
-13.723748232463446
Quarters > 2 > ratios > ROE
26.962798445308163
Quarters > 2 > ratios > ROA
-24.748993425411552
Quarters > 2 > ratios > FCF
21364000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
2.2643349231584526
Quarters > 2 > health Score
50
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
3765000
Quarters > 3 > income Statement > cost Of Revenue
329000
Quarters > 3 > income Statement > gross Profit
3436000
Quarters > 3 > income Statement > operating Expenses
15761000
Quarters > 3 > income Statement > operating Income
-11996000
Quarters > 3 > income Statement > interest Expense
4438000
Quarters > 3 > income Statement > pretax Income
-16792000
Quarters > 3 > income Statement > net Income
-16880000
Quarters > 3 > income Statement > eps
-0.5825943249721499
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
28973849
Quarters > 3 > income Statement > income Tax Expense
88000
Quarters > 3 > income Statement > EBITDA
-11551000
Quarters > 3 > income Statement > operating Margin
-318.6188579017264
Quarters > 3 > income Statement > total Other Income Expense Net
-4796000
Quarters > 3 > income Statement > currency_symbol
EUR
Quarters > 3 > balance Sheet > cash
19460000
Quarters > 3 > balance Sheet > short Term Investments
105000
Quarters > 3 > balance Sheet > receivables
2273000
Quarters > 3 > balance Sheet > inventories
829000
Quarters > 3 > balance Sheet > total Current Assets
27258000
Quarters > 3 > balance Sheet > property Plant Equipment
5434000
Quarters > 3 > balance Sheet > total Assets
36948000
Quarters > 3 > balance Sheet > payables
1849000
Quarters > 3 > balance Sheet > short Term Debt
6161000
Quarters > 3 > balance Sheet > long Term Debt
50541000
Quarters > 3 > balance Sheet > total Liabilities
77772000
Quarters > 3 > balance Sheet > equity
-40824000
Quarters > 3 > balance Sheet > currency_symbol
EUR
Quarters > 3 > cash Flow > net Income
-16880000
Quarters > 3 > cash Flow > depreciation
855000
Quarters > 3 > cash Flow > change In Working Capital
9233000
Quarters > 3 > cash Flow > cash From Operations
-163000
Quarters > 3 > cash Flow > capital Expenditures
172000
Quarters > 3 > cash Flow > cash From Investing
-423000
Quarters > 3 > cash Flow > cash From Financing
-6732000
Quarters > 3 > cash Flow > net Change In Cash
2634000
Quarters > 3 > cash Flow > currency_symbol
EUR
Quarters > 3 > ratios > PE
-0.5825943249721499
Quarters > 3 > ratios > PB
-18.083815219478737
Quarters > 3 > ratios > ROE
41.34822653341172
Quarters > 3 > ratios > ROA
-45.685828732272384
Quarters > 3 > ratios > FCF
-335000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.08897742363877822
Quarters > 3 > health Score
31
Annuals > 0 > quarter
2025-03-31
Annuals > 0 > income Statement > revenue
25541000
Annuals > 0 > income Statement > cost Of Revenue
1154000
Annuals > 0 > income Statement > gross Profit
25541000
Annuals > 0 > income Statement > operating Expenses
36381000
Annuals > 0 > income Statement > operating Income
-10840000
Annuals > 0 > income Statement > interest Expense
5088000
Annuals > 0 > income Statement > pretax Income
-18278000
Annuals > 0 > income Statement > net Income
-18438000
Annuals > 0 > income Statement > eps
-0.6335859303924862
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
29101025
Annuals > 0 > income Statement > income Tax Expense
160000
Annuals > 0 > income Statement > EBITDA
-11200000
Annuals > 0 > income Statement > operating Margin
-42.44156454328335
Annuals > 0 > income Statement > total Other Income Expense Net
-7438000
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
59040000
Annuals > 0 > balance Sheet > short Term Investments
12857000
Annuals > 0 > balance Sheet > receivables
3205000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
80617000
Annuals > 0 > balance Sheet > property Plant Equipment
5274000
Annuals > 0 > balance Sheet > total Assets
90452000
Annuals > 0 > balance Sheet > payables
3997000
Annuals > 0 > balance Sheet > short Term Debt
7294000
Annuals > 0 > balance Sheet > long Term Debt
49417000
Annuals > 0 > balance Sheet > total Liabilities
106819000
Annuals > 0 > balance Sheet > equity
-16367000
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
-18438000
Annuals > 0 > cash Flow > depreciation
1990000
Annuals > 0 > cash Flow > change In Working Capital
24534000
Annuals > 0 > cash Flow > cash From Operations
19465000
Annuals > 0 > cash Flow > capital Expenditures
1660000
Annuals > 0 > cash Flow > cash From Investing
-13210000
Annuals > 0 > cash Flow > cash From Financing
33324000
Annuals > 0 > cash Flow > net Change In Cash
39580000
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
-0.6335859303924862
Annuals > 0 > ratios > PB
-44.80636830207124
Annuals > 0 > ratios > ROE
112.65351011181035
Annuals > 0 > ratios > ROA
-20.38429222128864
Annuals > 0 > ratios > FCF
17805000
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
0.6971144434438745
Annuals > 0 > health Score
50
Annuals > 1 > quarter
2024-03-31
Annuals > 1 > income Statement > revenue
9160000
Annuals > 1 > income Statement > cost Of Revenue
2785000
Annuals > 1 > income Statement > gross Profit
9160000
Annuals > 1 > income Statement > operating Expenses
30137000
Annuals > 1 > income Statement > operating Income
-20977000
Annuals > 1 > income Statement > interest Expense
4617000
Annuals > 1 > income Statement > pretax Income
-24950000
Annuals > 1 > income Statement > net Income
-25038000
Annuals > 1 > income Statement > eps
-0.88101473417796
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
28419502
Annuals > 1 > income Statement > income Tax Expense
88000
Annuals > 1 > income Statement > EBITDA
-18614000
Annuals > 1 > income Statement > operating Margin
-229.00655021834064
Annuals > 1 > income Statement > total Other Income Expense Net
-3973000
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
19460000
Annuals > 1 > balance Sheet > short Term Investments
-729000
Annuals > 1 > balance Sheet > receivables
2273000
Annuals > 1 > balance Sheet > inventories
-19000
Annuals > 1 > balance Sheet > total Current Assets
27258000
Annuals > 1 > balance Sheet > property Plant Equipment
5433000
Annuals > 1 > balance Sheet > total Assets
36948000
Annuals > 1 > balance Sheet > payables
1849000
Annuals > 1 > balance Sheet > short Term Debt
6161000
Annuals > 1 > balance Sheet > long Term Debt
50541000
Annuals > 1 > balance Sheet > total Liabilities
77772000
Annuals > 1 > balance Sheet > equity
-40824000
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
-25038000
Annuals > 1 > cash Flow > depreciation
1719000
Annuals > 1 > cash Flow > change In Working Capital
3178000
Annuals > 1 > cash Flow > cash From Operations
-11922000
Annuals > 1 > cash Flow > capital Expenditures
1191000
Annuals > 1 > cash Flow > cash From Investing
-613000
Annuals > 1 > cash Flow > cash From Financing
25528000
Annuals > 1 > cash Flow > net Change In Cash
12993000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
-0.88101473417796
Annuals > 1 > ratios > PB
-17.5429024691358
Annuals > 1 > ratios > ROE
61.33156966490299
Annuals > 1 > ratios > ROA
-67.76550828190972
Annuals > 1 > ratios > FCF
-13113000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-1.4315502183406112
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2023-03-31
Annuals > 2 > income Statement > revenue
9944000
Annuals > 2 > income Statement > cost Of Revenue
-3766000
Annuals > 2 > income Statement > gross Profit
9944000
Annuals > 2 > income Statement > operating Expenses
33989000
Annuals > 2 > income Statement > operating Income
-24025000
Annuals > 2 > income Statement > interest Expense
3932000
Annuals > 2 > income Statement > pretax Income
-32010000
Annuals > 2 > income Statement > net Income
-32010000
Annuals > 2 > income Statement > eps
-1.2708180824907431
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
25188499
Annuals > 2 > income Statement > income Tax Expense
-3766000
Annuals > 2 > income Statement > EBITDA
-26413000
Annuals > 2 > income Statement > operating Margin
-241.60297666934832
Annuals > 2 > income Statement > total Other Income Expense Net
-7964000
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
6467000
Annuals > 2 > balance Sheet > short Term Investments
3000
Annuals > 2 > balance Sheet > receivables
2103000
Annuals > 2 > balance Sheet > inventories
760000
Annuals > 2 > balance Sheet > total Current Assets
19568000
Annuals > 2 > balance Sheet > property Plant Equipment
6373000
Annuals > 2 > balance Sheet > total Assets
29339000
Annuals > 2 > balance Sheet > payables
3591000
Annuals > 2 > balance Sheet > short Term Debt
43455000
Annuals > 2 > balance Sheet > long Term Debt
11708000
Annuals > 2 > balance Sheet > total Liabilities
71633000
Annuals > 2 > balance Sheet > equity
-42294000
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
-32010000
Annuals > 2 > cash Flow > depreciation
1665000
Annuals > 2 > cash Flow > change In Working Capital
-3036000
Annuals > 2 > cash Flow > cash From Operations
-21005000
Annuals > 2 > cash Flow > capital Expenditures
1027000
Annuals > 2 > cash Flow > cash From Investing
1298000
Annuals > 2 > cash Flow > cash From Financing
1556000
Annuals > 2 > cash Flow > net Change In Cash
-18150000
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
-1.2708180824907431
Annuals > 2 > ratios > PB
-15.008043098311816
Annuals > 2 > ratios > ROE
75.68449425450419
Annuals > 2 > ratios > ROA
-109.10392310576367
Annuals > 2 > ratios > FCF
-22032000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-2.2156074014481093
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2022-03-31
Annuals > 3 > income Statement > revenue
4090000
Annuals > 3 > income Statement > cost Of Revenue
-4248000
Annuals > 3 > income Statement > gross Profit
4090000
Annuals > 3 > income Statement > operating Expenses
27904000
Annuals > 3 > income Statement > operating Income
-23814000
Annuals > 3 > income Statement > interest Expense
1844000
Annuals > 3 > income Statement > pretax Income
-24806000
Annuals > 3 > income Statement > net Income
-24806000
Annuals > 3 > income Statement > eps
-0.997611018007631
Annuals > 3 > income Statement > dividends Per Share
2451000
Annuals > 3 > income Statement > shares Outstanding
24865403
Annuals > 3 > income Statement > income Tax Expense
-4247000
Annuals > 3 > income Statement > EBITDA
-21446000
Annuals > 3 > income Statement > operating Margin
-582.2493887530562
Annuals > 3 > income Statement > total Other Income Expense Net
-994000
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
24617000
Annuals > 3 > balance Sheet > short Term Investments
1968000
Annuals > 3 > balance Sheet > receivables
819000
Annuals > 3 > balance Sheet > inventories
1763000
Annuals > 3 > balance Sheet > total Current Assets
34074000
Annuals > 3 > balance Sheet > property Plant Equipment
7030000
Annuals > 3 > balance Sheet > total Assets
44303000
Annuals > 3 > balance Sheet > payables
2982000
Annuals > 3 > balance Sheet > short Term Debt
28345000
Annuals > 3 > balance Sheet > long Term Debt
16249000
Annuals > 3 > balance Sheet > total Liabilities
57674000
Annuals > 3 > balance Sheet > equity
-13371000
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
-24806000
Annuals > 3 > cash Flow > depreciation
1516000
Annuals > 3 > cash Flow > change In Working Capital
-2367000
Annuals > 3 > cash Flow > cash From Operations
-21362000
Annuals > 3 > cash Flow > capital Expenditures
1974000
Annuals > 3 > cash Flow > cash From Investing
-316000
Annuals > 3 > cash Flow > cash From Financing
-800000
Annuals > 3 > cash Flow > net Change In Cash
-22478000
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
-0.997611018007631
Annuals > 3 > ratios > PB
-46.86322306484182
Annuals > 3 > ratios > ROE
185.52090344776008
Annuals > 3 > ratios > ROA
-55.99169356476988
Annuals > 3 > ratios > FCF
-23336000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-5.705623471882641
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.4859769004702804
Valuation > metrics > PB
-27.519495493601465
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
52.48759467223818
Profitability > metrics > ROA
-26.204446182932394
Profitability > metrics > Net Margin
-1.3850792556857339
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-3.2192118226600983
Risk > final Score
17
Risk > verdict
High
Liquidity > metrics > Current Ratio
6.608789314950452
Liquidity > metrics > Quick Ratio
6.608789314950452
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
40
Prev Profitabilities > 1
40
Prev Profitabilities > 2
40
Prev Risks > 0
25
Prev Risks > 1
13
Prev Risks > 2
19
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:10:11.971Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-06-16
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-12-09
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-
Earnings History > 1 > eps Estimate
-0.16
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-06-17
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.17
Earnings History > 2 > eps Estimate
-0.17
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
0
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-02-26
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.17
Earnings History > 3 > eps Estimate
-0.18
Earnings History > 3 > eps Difference
0.01
Earnings History > 3 > surprise Percent
5.5556
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-12-10
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.5
Earnings History > 4 > eps Estimate
-0.19
Earnings History > 4 > eps Difference
-0.31
Earnings History > 4 > surprise Percent
-163.1579
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-28
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-0.2
Earnings History > 5 > eps Estimate
-0.2
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
0
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-06-10
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
-0.17
Earnings History > 6 > eps Estimate
-0.32
Earnings History > 6 > eps Difference
0.15
Earnings History > 6 > surprise Percent
46.875
Earnings History > 7 > period
2022-09-30
Earnings History > 7 > report Date
2022-12-06
Earnings History > 7 > date
2022-09-30
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
EUR
Earnings History > 7 > eps Actual
-0.55
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2022-03-31
Earnings History > 8 > report Date
2022-06-14
Earnings History > 8 > date
2022-03-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
EUR
Earnings History > 8 > eps Actual
-0.52
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.52
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2021-09-30
Earnings History > 9 > report Date
2021-12-08
Earnings History > 9 > date
2021-09-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
EUR
Earnings History > 9 > eps Actual
-0.47
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.47
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2021-06-30
Earnings History > 10 > report Date
2021-07-28
Earnings History > 10 > date
2021-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
EUR
Earnings History > 10 > eps Actual
-0.36
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.36
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2020-09-30
Earnings History > 11 > report Date
2020-12-09
Earnings History > 11 > date
2020-09-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
EUR
Earnings History > 11 > eps Actual
-0.5
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.5
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2020-06-30
Earnings History > 12 > report Date
2020-07-29
Earnings History > 12 > date
2020-06-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
EUR
Earnings History > 12 > eps Actual
-0.74
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.74
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2019-09-30
Earnings History > 13 > report Date
2019-12-04
Earnings History > 13 > date
2019-09-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
EUR
Earnings History > 13 > eps Actual
-0.45
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.45
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2019-06-30
Earnings History > 14 > report Date
2019-07-31
Earnings History > 14 > date
2019-06-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
EUR
Earnings History > 14 > eps Actual
-0.33
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.33
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2019-03-31
Earnings History > 15 > report Date
2019-06-04
Earnings History > 15 > date
2019-03-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
EUR
Earnings History > 15 > eps Actual
-1.36
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-1.36
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2018-09-30
Earnings History > 16 > report Date
2018-12-03
Earnings History > 16 > date
2018-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
EUR
Earnings History > 16 > eps Actual
-0.34
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.34
Earnings History > 16 > surprise Percent
-
MedinCell S.A., a clinical-stage and commercial biopharmaceutical licensing company, develops long acting injectables in various therapeutic areas in France. The company develops solutions based on BEPO, a long-acting injectable technology. It offers UZEDY (mdc-IRM) for the treatment of schizophrenia in adults and bipolar I disorder. It is also developing mdc-TJK, a subcutaneous injection that is in the NDA preparation stage for the treatment of schizophrenia in adults; and mdc-CWM, a sustained-release formulation of celecoxib in Phase III trials for use in the treatment of reduction of postoperative pain and inflammation in total knee arthroplasty surgery. In addition, its product candidates in preclinical trials include mdc-WWM for contraception; and mdc-STM for malaria. It has strategic collaborations with AbbVie to develop, manufacture, and commercialize six long-acting injectable therapeutic products; and IM4TB to develop a long-acting injectable version of Macozinone for the treatment of tuberculosis. MedinCell S.A. was incorporated in 2003 and is based in Jacou, France.
Stock Price
€0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/APre-market spike: MLMDV.PA Medical Devices Venture EURONEXT 20 Jan 2026 €9.40 Meyka
Read more →Why Globus Medical Stock Is Flying Higher in After-Hours Trading The Motley Fool
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
1
Buy
6
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Neutral
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Medincell SA
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2026-03-31
EPS Estimate
—
Date
2025-09-30
EPS Actual
—
EPS Estimate
-0.16
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2025-09-30)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.